DUE TO THE SIZE OF THE RISING JUNIOR CLASS THE SCHOOL OF MEDICINE WILL NOT BE ACCEPTING APPLICATIONS FOR ADVANCED STANDING IN 2014.
The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.
Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.
Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.
University of Maryland School of Medicine Dean Appoints New Associate Director for Basic Science at the Marlene and Stewart Greenebaum Cancer CenterUniversity of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., and Kevin Cullen, M.D., the Greenebaum Distinguished Professor in Oncology and Director of the Marlene and Stewart Greenebaum Cancer Center, have appointed Richard L. Eckert, Ph.D. to serve as Associate Director for Basic Science at the Greenebaum Cancer Center.
University of Maryland School of Medicine Recruits Renowned Cardiovascular Expert to Lead Newly Named Division of Cardiovascular MedicineUniversity of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., and Stephen Davis, M.B.B.S, the Dr. Theodore E. Woodward Professor and Chair in the Department of Medicine, have appointed renowned cardiovascular expert Sanjay Rajagopalan, M.D., F.A.C.C., F.A.H.A., to lead the newly named Division of Cardiovascular Medicine within the School’s Department of Medicine to new heights in research and patient care. The division was previously known as the Division of Cardiology.
Study: Bevacizumab (Avastin) Fails to Improve Survival for Patients Newly Diagnosed With GlioblastomaAdding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
University of Maryland School of Medicine Establishes New Brain Science Research Consortium To Study The Intricacies Of The BrainUniversity of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today the establishment of a new brain science research unit that will bring together faculty from multiple disciplines to probe the inner workings of the brain and to develop therapies for a wide range of neurological disorders.
University of Maryland School of Medicine Researchers Find Association Between Stroke and Cocaine UseResearchers from the University of Maryland School of Medicine and the Baltimore Veterans Affairs Medical Center have found a significant increase in the risk for ischemic stroke in young adults within 24 hours after cocaine use. The researchers presented their findings today at the American Stroke Association’s International Stroke Conference.